Health Care & Life Sciences » Biotechnology | BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp.
Stock Exchange NASDAQ Stock Market
EPS
$2.72
Market Cap
$438.68 M
Shares Outstanding
7.29 M
Public Float
5.34 M

Profile

Address
35 Wilbur Street
Lynbrook New York 11563
United States
Employees -
Website http://www.biospecifics.com
Updated 07/08/2019
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Financials

View All

Mark Wegman
Director
Toby Wegman
Director